Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,107.97 -99.48 (-0.15%) CMC Crypto 200
1,371.91 -45.97 (-3.24%)
Nexstim Plc (5NX.F)
| Previous close | 3.1800 |
| Open | 3.1200 |
| Bid | 3.0500 x N/A |
| Ask | 3.3500 x N/A |
| Day's range | 3.1100 - 3.1800 |
| 52-week range | 1.9400 - 4.3200 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 21.65M |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Insider Information: Nexstim Plc Provides Further Details on Technology License Agreement with Magnus Medical, Inc.
Company announcement, Helsinki, 12 June 2024 at 9 AM (EEST) Insider Information: Nexstim Plc Provides Further Details on Technology License Agreement with Magnus Medical, Inc. Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) announces that it has disagreements regarding the licensing of the Company’s technology to medical technology company Magnus Medical, Inc. (”Magnus Medical”). The technology licensed is related to the NBT® system developed by the Company, with certain restrictions, and the r
- GlobeNewswire
Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act
Company announcement, Helsinki, 11 June 2024 at 2 PM (EEST) Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) has received a notification pursuant to chapter 9, section 5 of the Securities Market Act from Kyösti Kakkonen on 10 June 2024. The notification is based on the amendment to the Securities Market Act effective April 19, 2024, requiring shareholders to notify the target compan
- GlobeNewswire
Distributor Orders Nexstim NBS System 5 for European Hospital
Press release, Helsinki, 10 June 2024 at 9 AM (EEST) Distributor Orders Nexstim NBS System 5 for European Hospital Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a distributor for a European hospital. The Nexstim Navigated Brain Stimulation (NBS) System 5 is indicated for non-invasive mapping of the primary motor cortex of the brain to its cortical gyrus and localization of cortical areas that do not contain essential speech function. The informat
